Clinical Trials

Dr. Shen Lee is the co-founder of Vision Optique and the founder of Ocular Aesthetics. Founded in 1999, Vision Optique is a private optometric practice in Houston. It is a modern contact lens practice, an innovative high-end optical, and a comprehensive ocular health center. Ocular Aesthetics is focused on the latest innovations in contact lenses, ophthalmic lenses, presbyopia, ocular aesthetics, myopia management, and ocular surface disease treatments.

Ocular Aesthetics d/b/a Ocular Clinical Trials has successfully completed multiple studies in ocular surface disease, specialty contact lenses for children and adults, and myopia management. 

Dr. Shen Lee serves as both the medical director and principal investigator for ocular aesthetics. She is a fellow of the American Academy of Optometry, a fellow of the British Contact Lens Association, and a fellow of the European Academy of Optometry and Optics. Dr. Shen Lee lectures internationally on the topics of Digital Eye Health®, dry eye disease, anti-aging eye care, and myopia management. She is also fluent in Mandarin.

Dr. Owens is the co-founder of Vision Optique and also serves as a sub-investigator for Ocular Aesthetics. He has extensive clinical training in cornea, cataract, and refractive surgery co-management. 

Dr. Owens specializes in custom contact lenses for patients who suffer from corneal dystrophies, such as keratoconus. Dr. Owens enjoys providing both primary eye care and working as a sub-investigator for studies in myopia management, contact lenses, and diagnostic technologies.

Dr. Abraham completed a fellowship in refractive surgery and ocular disease at Parkhurst NuVision, gaining experience in managing complex conditions, such as dry eye, glaucoma, cataracts, keratoconus, and others. She previously conducted over 20 research studies focusing on dry eye, glaucoma therapy devices, and cataract intraocular lenses (IOLs). 

Since joining our team, Dr. Abraham has been a sub-investigator for multiple clinical trial studies in ocular surface disease, contact lenses, and diagnostic technologies. Dr. Abraham is dedicated to furthering the future of eye care through research.

Fatima plays a key role in the organization and execution of our clinical studies. Acting as a study coordinator for FDA-approved clinical studies, she works closely with our sponsors and every patient who participates in our studies. She holds 2 graduate degrees and has 6 years of clinical research experience.

Her background spans stem cell research, immunology, and biotechnology. Fatima is dedicated to making a difference in our patients’ vision and eye health. Fatima is also fluent in Arabic and French.